Sun Pharma Advanced Research wins ₹28 crore CENVAT credit refund case in CESTAT

On Thursday (October 1), shares of Sun Pharma Advanced Research Company Ltd ended at ₹194.90, down by ₹2.30, or 1.17%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *